This opportunity is no longer accepting applications.
grant PAR-22-189

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

This grant opportunity invites applications for developing and conducting investigator-initiated single site clinical trials. These trials can focus on various strategies like therapeutic, behavioral, or prevention and must align with the NHLBI's research mission and the NIH definition of a clinical trial. The funding follows a two-phase, milestone-driven model. Applicants need to present a st…

This Funding Opportunity Announcement (FOA) supports applications to develop and implement investigator-initiated single site clinical trials including efficacy, comparative effectiveness, pragmatic and/or implementation research clinical trials. These trials may include ones that test different…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute
Program: SBIR

Dates

Opportunity Released: July 12, 2022
Open for Submission: July 12, 2022
Submission Deadline: September 11, 2025
Application Window Closes: September 11, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.